Articles at Genital-Herpes-Facts
|
Genital Herpes Article
![]()
Herpes Dating
from:Herpes is a viral disease that is prevalent in people in the
USA, but involves no visible symptoms in most cases. The result
is that people are not even aware that they have either oral or
genital herpes. It has been observed that people generally go
into a shell when they realize they have the disease and their
social interactions become awkward. This becomes all the more
highlighted if an infected person is dating someone.
First and foremost, a person with herpes should realize that the
disease is a common ailment that can be controlled and is not in
any way the end of the world. Recent studies have shown that
proper treatment and precaution can prevent transmission of the
disease.
All this means is that people with herpes should keep their
heads up and confidence level high. The saying 'smile and the
world will smile with you' may sound clichéd, but can be very
useful in this situation.
The trials and tribulations serve to test the strength the
relationships of the person with herpes. It is important for the
infected person to be honest with themselves and their partner.
Disclosing private information and facing rejection is never
easy, but if the infected person's partner really cares for
them, he or she will realize their trauma and reach out to them.
On the practical side, honesty will lead to communication that
will not spread transmission.
There is more to a relationship than sexual interaction. by
looking at its positive side, one will find that herpes will
provide the perfect opportunity to explore other alternatives of
intimacy bonding at a level that goes will beyond physical.
About the author:
Herpes provides detailed
information on Genital Herpes, Herpes, Herpes And Pregnancy,
Herpes Cure and more. Herpes is affliated with href="http://www.e-HepatitisC.com">Hepatitis C Treatments.
Genital Herpes News
Antigenics Presents Positive, Top Line Data From Phase I Herpes Clinical Trial
Antigenics (NASDAQ: AGEN) announced positive results with AG-707, an investigational therapeutic vaccine being developed to treat herpes simplex virus-2 (HSV-2), the virus that causes genital herpes, in infected patients. Developed by Antigenics, the vaccine triggers a cellular immune response, stimulating both CD4+ and CD8+ T cells. "I believe these data represent the first finding of their ...
Read more...Antigenics announces positive result for AG-707 to treat genital herpes
Antigenics announced positive results with AG-707, an investigational therapeutic vaccine being developed to treat herpes simplex virus-2,the virus that causes genital herpes, in infected patients. Developed by Antigenics, the vaccine triggers a cellular immune response, stimulating both CD4+ and CD8+ T cells.
Read more...Antigenics posts positive herpes drug study data
Antigenics reported positive data Tuesday from an early stage clinical therapy trial to treat herpes simplex virus-2, the virus that causes genital herpes.
Read more...Antigenics shares up on progress with herpes drug
NEW YORK (MarketWatch) - Antigenics Inc. shares leaped 20% in Tuesday trading. The Salt Lake City biotechnology company, which is focused on treatments for cancer and infectious diseases, reported progress in a Phase I trial of AG-707, a drug under development to treat herpes simplex virus-2, the virus that causes genital herpes. "Being able to impact and possibly decrease the spread of genital ...
Read more...Collaboration Solves Structure Of Herpes Virus Protein, Provides New Drug Directions
The mechanism by which a herpes virus invades cells has remained a mystery to scientists, but now research from Tufts University and the University of Pennsylvania reveals the unusual structure of a key member of the protein complex that allows a herpes virus to invade cells.The new map details an essential piece of the herpes virus cell-entry machinery, providing scientists with a new target ...
Read more...





